Advisor Group Holdings, Inc. Clene Inc. Transaction History

Advisor Group Holdings, Inc.

  • $43.4 Billion
  • Q1 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Clene Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 16,250 shares of CLNN stock, worth $5,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,250
Previous 16,250 -0.0%
Holding current value
$5,362
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.46 - $0.87 $5,175 - $9,787
11,250 Added 225.0%
16,250 $8,000
Q2 2021

Aug 02, 2021
BUY
$6.98 - $13.33 $34,900 - $66,650
5,000 New
5,000 $56,000

Others Institutions Holding CLNN

# of Institutions
54
Shares Held
7.44M
Call Options Held
48.1K
Put Options Held
160K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $21M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email